Fighting blindness with a minimally invasive retinal stimulator

视网膜退行性病变是发达国家失明的主要原因，全世界有超过 2 亿人受其困扰。我们的团队首创了一种微创治疗刺激器，可以在不妨碍视力的情况下阻止视网膜变性。我们现在已准备好进行必要的转化研究，以开发和测试人类级设备。最终目标是成为第一个开发出可防止视力丧失的商业治疗刺激器的公司。

Retinal degenerative conditions are the leading cause of blindness in developed nations, with over 200 million people afflicted worldwide. Our group has pioneered a minimally-invasive therapeutic stimulator that can arrest retinal degeneration without blocking vision. We are now ready to perform the prerequisite translational studies to develop and test a human-grade device. The ultimate goal is to be the first to develop a commercial therapeutic stimulator that protects against vision loss.